Skip to main content
HR 3520 116th Congress House Health Advisory bodies Blood and blood diseases Cell biology and embryology Health programs administration and funding Medical research Organ and tissue donation and transplantation Research administration and funding

Stem Cell Therapeutic and Research Reauthorization Act of 2019

Introduced: June 26, 2019 Introduced by: Smith, Christopher H. Republican · New Jersey See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 27, 2019
Referred to the Subcommittee on Health.
Jun 26, 2019
Referred to the House Committee on Energy and Commerce.
Jun 26, 2019
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Stem Cell Therapeutic and Research Reauthorization Act of 2019

This bill modifies and reauthorizes through FY2024 the C.W. Bill Young Cell Transplantation Program, which provides support to patients who need a potentially life-saving bone marrow transplant or umbilical cord blood transplant. It also reauthorizes through FY2024 the Stem Cell Therapeutic and Research Act of 2005, which provides for the collection and maintenance of new units of high-quality cord blood.

The bill requires the Advisory Council on Blood Stem Cell Transplantation to convene at least twice per calendar year.

What's happening now June 27, 2019

Referred to the Subcommittee on Health.

 Related & companion bills 2
  • HR 4764 Related bill TRANSPLANT Act of 2020
  • S 4672 Related bill TRANSPLANT Act of 2020
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 2
All 2 Republican 1
Luetkemeyer, Blaine
· Sep 17, 2019
 R
Bilirakis, Gus M.
Florida · Jun 26, 2019
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 3520: Stem Cell Therapeutic and Research Reauthorization Act of 2019. 116th Congress. Open America. https://openamerica.io/bill/116-HR-3520/
MLA
"H.R. 3520: Stem Cell Therapeutic and Research Reauthorization Act of 2019." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-3520/.
Bluebook (legal)
H.R. 3520, 116th Cong. (2026), https://openamerica.io/bill/116-HR-3520/.
Markdown link
[H.R. 3520: Stem Cell Therapeutic and Research Reauthorization Act of 2019](https://openamerica.io/bill/116-HR-3520/)
Report a problem